ArticleOncology and therapy2026

Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial.

Yuping Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.